13 November 2017 - Medicines regulator and network of health technology assessment bodies continue to strengthen their collaboration
The EMA and the European Network for Health Technology Assessment (EUnetHTA) have published a joint work plan outlining key areas of collaboration for the next three years.
The EMA-EUnetHTA collaboration, which began in 2010, aims to harness synergies between regulatory evaluation and health technology assessment (HTA) along the lifecycle of a medicine whilst respecting their different remits. The overall goal is to improve the efficiency and quality of processes and ensure mutual understanding and dialogue on evidence needs. This facilitates improved access to medicines for patients in the European Union.